Propionylpromazine: Unveiling a Novel Inhibitory Agent Against Mycobacterium tuberculosis
Suresh, U.; Punnam, M.; Kartick, C.; Sugunan, P. A.
Show abstract
The emergence of multidrug-resistant mycobacterium tuberculosis presents a significant hurdle, as it shows resistance to existing standard therapies, underscoring the critical need for novel antibacterial agents. This study presents propionylpromazine as a promising compound with potent activity against M. tuberculosis. Our research indicates that propionylproma zine effectively curtails the proliferation of M. tuberculosis H37Rv. Importantly, propionylpromazine has shown the capability to impede the growth of M. tuberculosis within macrophages without causing detrimental effects. These findings endorse the potential of propionylpromazine to be further developed as a clinical drug for the effective treatment of M. tuberculosis infections.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine and Linezolid in a Murine Model of Tuberculosis. 96%
- GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment 96%
- In vitro and in vivo activity of Gepotidacin against drug-resistant mycobacterial infections 95%
Similar papers in this journal
- Novel Pentafluorosulfanyl-containing Triclocarban Analogs selectively kill Gram-positive bacteria. 95%
- Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity 93%
- The antimicrobial potential of traditional remedies of Indigenous Peoples from Canada against MRSA planktonic and biofilm bacteria in wound-infection mimetic conditions 92%
Similar papers in this journal
- Structural requirements for dihydrobenzoxazepinone anthelmintics: actions against medically important and model parasites - Trichuris muris, Brugia malayi, Heligmosomoides polygyrus and Schistosoma mansoni 93%
- Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi 93%
- Legacy 4(1H)-quinolone scaffolds activity against acute and chronic Toxoplasma gondii infection 92%
Similar papers in this journal
- Exploration of clinical breakpoint of Danofloxacin for Glaesserella parasuis in plasma and in PELF 94%
- Structure-activity relationship of pyrrolidine pentamine derivatives as inhibitors of the aminoglycoside 6'-N-acetyltransferase type Ib 94%
- Repurposing disulfiram (Tetraethylthiuram Disulfide) as a potential drug candidate against Borrelia burgdorferi in vitro and in vivo 93%
Similar papers in this journal
- Drug screening to identify compounds to act as co-therapies for the treatment of pathogenic Burkholderia 94%
- A screening of the MMV Pathogen Box(R) reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis 94%
- High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.